SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

CEO Angelos Stergious 15th-anniversary post highlighting GPS and SLS009 has fueled bullish interpretations and speculation about a potential buyout, though no deal is confirmed. The main debate centers on the REGAL Phase 3 trials final analysis: traders view the wait for the 80-event trigger as a possible sign of prolonged survival, while skeptics stress the uncertain, binary clinical outcome.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst is drawing attention for continued share-price weakness despite growing ORLADEYO sales and raised revenue guidance. Traders are divided between seeing the profitable business and pipeline as undervalued and doubting managements acquisition-led strategy, with sentiment hinging on future navenibart and Netherton data amid HAE competition.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to fresh lows dominates discussion, with traders linking the weakness to deteriorating sentiment around Trump ahead of the midterms and the companys limited operating performance; bearish views prevail, though some see potential for a short-term bounce.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as Middle East conflict and reported attacks on shipping and energy infrastructure fuel concerns about oil supply disruptions. Traders are split between betting that those risks will keep oil elevated and expecting peace-deal headlines or a normalization of flows to unwind the risk premium, contributing to sharp swings.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriad Genetics sharp rally is tied to its agreement to sell its Prenatal Health testing business to Labcorp for cash, which traders view as a strategic reshaping that could strengthen the balance sheet. The reaction is divided: bulls cite the deal and heavy-volume momentum, while skeptics argue the divested unit was an important revenue source and worry about the remaining business and debt.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas planned public listing of its Monee financial-services arm and launch of an AI enterprise platform are driving the discussion as shares sell off. Traders worry that a separation could weaken the remaining business or take time to complete, while some view the listing as a way to unlock Monees value.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs steep selloff is being debated amid broader fears about neocloud financing and Gartners warning that many independent AI infrastructure providers could consolidate. Bullish traders point to CEO Daniel Roberts comments that IRENs data centers carry no debt and customer prepayments help fund GPU costs, while bears remain focused on weak price action and execution risks.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs quarterly earnings beat and higher full-year guidance have been overshadowed by a sharp share-price decline, with traders focusing on rising costs, weaker cash flow, and an insurance-business loss. The community is split between seeing strong orders and services demand as evidence of durable momentum and questioning whether that demand will translate into better margins and cash generation.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTXs quarterly earnings beat, raised full-year outlook and record backlogsupported by long-term missile contracts and strong defense demandare driving attention. Traders welcome the results and demand outlook, but many are frustrated that the share price has stayed weak or turned red despite the positive news.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Unconfirmed Iran-U.S. deal chatter and a pullback in oil dominated discussion, with traders linking the headlines to a sharp QQQ rebound and volatile reversals. Bulls framed the move as a relief rally, while skeptics questioned the reports and warned of a bull trap; tech earnings and AI-sector weakness added uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million.
Geovax Labs (NASDAQ:GOVX) stock roseread more...

GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

GeoVax Labs (GOVX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Why Is GOVX Stock Falling Today?

Equity

GeoVax announced the discontinuation of its development of a COVID-19 vaccine candidate and also came out with a share resale plan.

Why Is GeoVax Labs Stock Falling Tuesday?

GOVX stock pulls back premarket after an 80% rally as GeoVax Labs announces a $3M private placement, sparking dilution fears.read more...

GOVX Stock Soars 80%: Retail Traders Are Piling In As Ebola, Hantavirus Risks Resurface

CEO David A. Dodd said GEO-MVA remains central to GeoVax’s biodefense and vaccine supply strategy.

All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy

GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock?

GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement. 


Emergent, Geovax, Tonix, Siga: Which Mpox-Linked Stocks Are Retail Investors Most Excited About?

Among the four U.S.-listed pharma stocks, retail investors are ‘extremely bullish’ on Emergent Biosolutions as it expressed readiness to scale up response efforts for the WHO health emergency.

These Three Stocks are Experiencing an Outbreak– Or a Breakout Depending How you Look at it

The monkeypox outbreak has boosted stocks of GeoVax Labs, Tonix Pharmaceuticals, and Chimerix. These companies are developing vaccines and treatments related to smallpox and viral diseases, positioning them as key players in addressing this health crisis.

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.

Geovax Labs Inc

Neutral Sentiment

<ul class="summary-bullets"><li>GeoVax to focus on the development of its lead vaccine and cancer therapy programs.</li><li>The company also filed a prospectus with the SEC for the resale of up to 7.6 million shares of common stock.</li><li>The vaccine maker added that its current cash and cash equivalents are expected to support operations through August 2026.</li></ul>Shares of GeoVax Labs (GOVX) plunged 12% on Tuesday as investors reacted to a resale prospectus for more than seven million shares, and the biotech firm’s announcement that it had scrapped development of its COVID-19 vaccine candidate.<a href="https://stocktwits.com/symbol/GOVX">GeoVax Labs shares</a> suffered their steepest single-day decline in more than two months, putting the stock on track to snap a blistering three-session rally that had lifted its value by nearly 82%.<h2 class="st-heading-2">GOVX To Focus On Smallpox, Cancer Therapies</h2>GeoVax said it is sharpening its focus on its lead vaccine and cancer therapy programs while discontinuing development of its COVID-19 vaccine candidate, GEO-CM04S1, as demand in the global COVID vaccine market continues to weaken.The company said the move was not tied to safety concerns but was aimed at prioritizing programs with stronger commercial and regulatory opportunities.GeoVax will now concentrate resources on GEO-MVA, its mpox and smallpox vaccine candidate, and Gedeptin, its cancer therapy. GEO-MVA is advancing under an expedited regulatory pathway supported by the European Medicines Agency (EMA) and could move toward commercialization following a planned Phase 3 study.Meanwhile, Gedeptin is being developed alongside immunotherapy treatments for head and neck cancers.<h2 class="st-heading-2">7.6M Share Resale</h2>GeoVax also filed a prospectus with the SEC on Tuesday for the resale of up to 7.6 million shares of common stock tied to warrant exercises and a private placement completed earlier this month.The company said it will not receive any proceeds from the resale of the shares, but could receive cash proceeds if investors exercise the outstanding warrants. On May 18, the company raised about $2.7 million through a private placement.GeoVax also added that its current cash and cash equivalents are expected to support operations through August 2026.<h2 class="st-heading-2">What Does Retail Think Of GOVX?</h2>Despite the decline, retail sentiment for GOVX on Stocktwits remained in the ‘extremely bullish’ zone over the past 24 hours, amid ‘extremely high’ message volumes.One user said any chance of a rally is ‘dead’ after the firm significantly increased its free float. According to Koyfin data, the company has 2.89 million shares outstanding.<stembedurl>https://stocktwits.com/BarelySocialGator/message/654375360</stembedurl>The stock has declined more than 22% so far in 2026.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/grrr-stock-gains-data-centre-deal-2b-revenue-potential/cZgO3SlReqQ">GRRR’s New Deal Comes With A $2B Revenue Potential – Third Data Center Infra Deal In A Month Gets Retail Eyeing $100 Mark For The Stock</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Geovax previously published research suggesting its vaccines could help prevent mpox.

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$0.228
Prev Close	$0.2275
Open	$0.23
Dividend Yield	0.00%
50-Day Moving Average	$0.4667
Beta	1.60
Avg. Volume	300,077.14
PE Ratio	-0.02

52-Week High	$15.17
52-Week Low	$0.226
Market Capitalization	$2.3M
EPS (Annual)	-$22.40
Price to Book	0.95
Revenue Per Employee	$131,007.63

Feed

News

Sentiment

Earnings

Fundamentals

Info

GOVX Fundamentals